BlackRock, Eclipse Lead Cellares' $257M Funding Round
Integrated development and manufacturing organization company Cellares, which focuses on the large-scale manufacturing of cell therapies, on Wednesday announced that it closed a $257 million funding round, bringing the South San...To view the full article, register now.
Already a subscriber? Click here to view full article